Association between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: A case-control study

Abstract

Recent population-based genome wide association studies have revealed potential susceptibility loci of lung cancer at the region of chromosome 15q25.1 containing nicotinic acetylcholine receptor genes. The loci increasing lung cancer risk has been widely identified in Caucasians, but whether this association also exists in Asians and whether this association is a direct role or mediated via tobacco smoking indirectly has not been fully established. We conducted a case-control study comprising of 210 histologically confirmed lung cancer cases and 200 healthy controls to examine rs1051730 genotyping, a single nucleotide polymorphism receiving much attention recently, and its influence on lung cancer risk as well as nicotine dependence in a Chinese Han population. Our results showed that the heterozygous C/T genotype and minor allele T conferred a significant higher risk of lung cancer than the CC homozygotes and allele C (adjusted OR=2.25, 95% CI=1.04–4.89, P=0.040 and OR=2.18, 95% CI=1.02–4.67, P=0.045 respectively). However, no association between the smoking habit and the CHRNA3 rs1051730 polymorphism was observed in this study. The results suggested that the rs1051730 polymorphism may modify susceptibility to lung cancer via a smoking-independent manner among Chinese Han population. Additional studies in vitro and in vivo are warranted to further elucidate the impact of rs1051730 on lung cancer susceptibility.

Keywords

rs1051730 / gene polymorphism / lung cancer / susceptibility

References

[1] ChenJ, LiZ, ZhangS, et al.. Effects of exogenous VEGF(165)b on invasion and migration of human lung adenocarcinoma A549 cells. J Huazhong Univ Sci Technol [Med Sci], 2011, 31(5): 619-624

[2] TakahashiT. Lung cancer: an ever increasing store of in-depth basic knowledge and the beginning of its clinical application. Oncogene, 2002, 21(45): 6868-6869

[3] HouwenL. State of the art: lung cancer in China. Ann Thorac Cardiovasc Surg, 2003, 9(3): 147-148

[4] Janssen-HeijnenML, GattaG, FormanD, et al.. Variation in survival of patients with lung cancer in Europe, 1985–1989. EUROCARE Working Group. Eur J Cancer, 1998, 34(14Spec): 2191-2196

[5] SametJM, Avila-TangE, BoffettaP, et al.. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res, 2009, 15(18): 5626-5645

[6] ThunMJ, HannanLM, Adams-CampbellLL, et al.. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med, 2008, 5(9): e185

[7] AmosCI, WuX, BroderickP, et al.. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet, 2008, 40(5): 616-622

[8] HungRJ, McKayJD, GaborieauV, et al.. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 2008, 452(7187): 633-637

[9] ThorgeirssonTE, GellerF, SulemP, et al.. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 2008, 452(7187): 638-642

[10] TsurutaniJ, CastilloSS, BrognardJ, et al.. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis, 2005, 26(7): 1182-1195

[11] WestKA, BrognardJ, ClarkAS, et al.. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest, 2003, 111(1): 81-90

[12] BierutLJ, StitzelJA, WangJC, et al.. Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry, 2008, 165(9): 1163-1171

[13] SacconeSF, HinrichsAL, SacconeNL, et al.. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet, 2007, 16(1): 36-49

[14] SoriceR, BioneS, SansanelliS, et al.. Association of a variant in the CHRNA5-A3-B4 gene cluster region to heavy smoking in the Italian population. Eur J Hum Genet, 2011, 19(5): 593-596

[15] WangJ, SpitzMR, AmosCI, et al.. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer, 2010, 116(14): 3458-3462

[16] WeiS, WangLE, McHughMK, et al.. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis, 2012, 33(8): 1531-1537

[17] GalvanA, DraganiTA. Nicotine dependence may link the 15q25 locus to lung cancer risk. Carcinogenesis, 2010, 31(3): 331-333

[18] ShiraishiK, KohnoT, KunitohH, et al.. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis, 2009, 30(1): 65-70

[19] SinhaP, LoganHL, MendenhallWM. Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol, 2012, 33(1): 130-136

[20] WuC, HuZB, YuDK, et al.. Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res, 2009, 69(12): 5065

[21] GuML, DongXQ, ZhangXZ, et al.. Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis. Plos ONE, 2012, 7(6): e37970

[22] WuM, ZhaoJK, ZhangZF, et al.. Smoking and alcohol drinking increased the risk of esophageal cancer among Chinese men but not women in a high-risk population. Cancer Causes Control, 2011, 22(4): 649-657

[23] De StefaniE, BoffettaP, CarzoglioJ, et al.. Tobacco smoking and alcohol drinking as risk factors for stomach cancer: a case-control study in Uruguay. Cancer Causes Control, 1998, 9(3): 321-329

[24] MatsuoK, ItoH, WakaiK, et al.. Cigarette smoking and pancreas cancer risk: an evaluation based on a systematic review of epidemiologic evidence in the Japanese population. Jpn J Clin Oncol, 2011, 41(11): 1292-1302

[25] BarisD, KaragasMR, VerrillC, et al.. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst, 2009, 101(22): 1553-1561

[26] LynchHT, LynchJF. Cigarette smoking and breast cancer risk. Women’s Health, 2011, 7(4): 413-416

[27] SpitzMR, AmosCI, DongQ, et al.. The CHRNA5-A3 region on chromosome 15q24–25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst, 2008, 100(21): 1552-1556

[28] JaworowskaE, TrubickaJ, LenerMR, et al.. Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PloS ONE, 2011, 6(9): e25057

[29] ChenJ, WuX, PandeM, et al.. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas, 2011, 40(6): 872-875

[30] Le MarchandL, DerbyKS, MurphySE, et al.. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res, 2008, 68(22): 9137-9140

[31] BroderickP, WangY, VijayakrishnanJ, et al.. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res, 2009, 69(16): 6633-6641

[32] GanQ, SmithKR, HammondSK, et al.. Disease burden of adult lung cancer and ischaemic heart disease from passive tobacco smoking in China. Tob Control, 2007, 16(6): 417-422

[33] TaylorR, NajafiF, DobsonA. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol, 2007, 36(5): 1048-1059